盟科药业(688373.SH)：新增生产商的康替唑胺原料药上市登记获得批准

Group 1 - The core point of the article is that Amgen Pharmaceutical (688373.SH) has received approval from the National Medical Products Administration for the registration of a new raw material supplier, Chongqing Boteng Pharmaceutical Technology Co., Ltd., for the production of its drug, Contizolam tablets [1] - Boteng's raw material for Contizolam can now be used for the commercial production of Contizolam tablets, which are a new generation of oxazolidinone antibiotics developed by the company [1] - Contizolam tablets are indicated for the treatment of complex skin and soft tissue infections [1]